LISATA THERAPEUTICS, INC. Business Acquisition, Contingent Consideration, at Fair Value, Noncurrent (Deprecated 2013-01-31)
LISATA THERAPEUTICS, INC. (LSTA) had Business Acquisition, Contingent Consideration, at Fair Value, Noncurrent (Deprecated 2013-01-31) of $9.45 million as of 2013-12-31, per its 10-K filed 2014-03-13.
Discontinued › Notes › Business Combinations
us-gaap:BusinessAcquisitionContingentConsiderationAtFairValueNoncurrent · last filed 2014-03-13
- 2013-12-31: Business Acquisition, Contingent Consideration, at Fair Value, Noncurrent (Deprecated 2013-01-31) $9.45M.
- 2013-09-30: Business Acquisition, Contingent Consideration, at Fair Value, Noncurrent (Deprecated 2013-01-31) $7.55M.
- 2013-06-30: Business Acquisition, Contingent Consideration, at Fair Value, Noncurrent (Deprecated 2013-01-31) $7.55M.
- 2013-03-31: Business Acquisition, Contingent Consideration, at Fair Value, Noncurrent (Deprecated 2013-01-31) $7.55M.
| Period end | Business Acquisition, Contingent Consideration, at Fair Value, Noncurrent (Deprecated 2013-01-31) |
|---|---|
| 2013-12-31 | $9.45M 10-K · filed 2014-03-13 |
| 2013-09-30 | $7.55M 10-Q · filed 2013-11-07 |
| 2013-06-30 | $7.55M 10-Q · filed 2013-08-08 |
| 2013-03-31 | $7.55M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $7.55M 10-K · filed 2014-03-13 |
| 2012-09-30 | $3.13M 10-Q · filed 2012-11-13 |
| 2012-06-30 | $3.13M 10-Q · filed 2012-08-14 |
| 2012-03-31 | $3.13M 10-Q · filed 2012-05-11 |
| 2011-12-31 | $3.13M 10-K · filed 2013-03-11 |
| 2010-12-31 | $0.00 8-K · filed 2012-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |